Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Blood coagulation factor IX: structural insights impacting hemophilia B therapy

Class:IdLiteratureReference:9934451
_displayNameBlood coagulation factor IX: structural insights impacting hemophilia B therapy
_timestamp2025-01-08 19:24:32
author[Person:9930532] Bos, Mettine H A
[Person:9934464] van Diest, Rianne E
[Person:158396] Monroe, DM
created[InstanceEdit:9934473] Shamovsky, Veronica, 2025-01-08
journalBlood
pages2198-2210
pubMedIdentifier38996207
titleBlood coagulation factor IX: structural insights impacting hemophilia B therapy
volume144
year2024
(literatureReference)[Summation:158220] In the presence of Ca²⁺ and phospholipids, factor IXa (FIXa)...
[Summation:158301] Factors VIIIa (FVIIIa) and FIXa associate on membrane surfac...
[Summation:5606995] Activated factor IX (FIXa) binds to anionic phospholipid sur...
[Change default viewing format]
No pathways have been reviewed or authored by Blood coagulation factor IX: structural insights impacting hemophilia B therapy (9934451)